首页> 美国卫生研究院文献>Sensors (Basel Switzerland) >A Novel Laser Refractive Surgical Treatment for Presbyopia: Optics-Based Customization for Improved Clinical Outcome
【2h】

A Novel Laser Refractive Surgical Treatment for Presbyopia: Optics-Based Customization for Improved Clinical Outcome

机译:一种用于老花眼的新型激光屈光手术治疗:基于光学的定制可改善临床结果。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Laser Assisted in Situ Keratomileusis (LASIK) is a proven treatment method for corneal refractive surgery. Surgically induced higher order optical aberrations were a major reason why the method was only rarely used to treat presbyopia, an age-related near-vision loss. In this study, a novel customization algorithm for designing multifocal ablation patterns, thereby minimizing induced optical aberrations, was used to treat 36 presbyopic subjects. Results showed that most candidates went from poor visual acuity to uncorrected 20/20 vision or better for near (78%), intermediate (92%), and for distance (86%) vision, six months after surgery. All subjects were at 20/25 or better for distance and intermediate vision, and a majority (94%) were also better for near vision. Even though further studies are necessary, our results suggest that the employed methodology is a safe, reliable, and predictable refractive surgical treatment for presbyopia.
机译:激光辅助原位角膜磨镶术(LASIK)是一种行之有效的角膜屈光手术治疗方法。手术引起的高阶像差是该方法很少用于治疗老花眼的主要原因,老花眼是一种与年龄有关的近视力丧失。在这项研究中,一种新颖的定制算法,用于设计多焦点消融模式,从而最大程度地减少了诱发的光学像差,被用于治疗36位老花眼患者。结果表明,大多数候选人在术后六个月从近视力(78%),中度(92%)和远距离(86%)的视力差转向未矫正的20/20视力或更好。所有受试者的远距离和中视均在20/25或更高,大多数(94%)的近视也更好。尽管有必要进行进一步的研究,但我们的结果表明,所采用的方法对老花眼是一种安全,可靠且可预测的屈光手术治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号